- Home
- FNRN vs RNAC Comparison
FNRN vs RNAC Comparison
Compare FNRN & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$10.22
Company Overview
Basic Information| Metric | FNRN | RNAC |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 295.8M | 238.9M |
| IPO Year | 2000 | 2016 |
Fundamental Metrics
Financial Performance| Metric | FNRN | RNAC |
|---|---|---|
| Price | $17.49 | $10.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $34.00 |
| AVG Volume (30 Days) | 109.6K | ★ 120.9K |
| Earning Date | N/A | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.42 | N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | N/A | ★ $2,797,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $27.34 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.93 | $5.60 |
| 52 Week High | $19.25 | $11.34 |
Technical Indicators
Market Signals| Indicator | FNRN | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 46.23 | 67.73 |
| Support Level | $17.55 | $5.88 |
| Resistance Level | $17.75 | $10.98 |
| Average True Range (ATR) | 0.49 | 0.56 |
| MACD | -0.01 | 0.21 |
| Stochastic Oscillator | 64.41 | 74.73 |
Price Performance
Historical Comparison FNRN
RNAC
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.